Related Experiment Video
Updated: Jun 4, 2026
16:56
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
Sublingual immunotherapy in patients with allergic rhinoconjunctivitis
Deborah Gentile1, David P Skoner
1Division of Allergy, Asthma, and Immunology, Department of Internal Medicine, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, USA. dgentile@wpahs.org
Current Allergy and Asthma Reports
|January 29, 2011
Summary
Sublingual immunotherapy (SLIT) is effective for allergic rhinitis. Recent US studies confirm the safety and efficacy of SLIT, offering new insights into its mechanisms.
Area of Science:
- Allergy and Immunology
- Immunotherapy
- Otolaryngology
Background:
- Sublingual immunotherapy (SLIT) is a recognized treatment for allergic rhinitis in Europe.
- SLIT is considered investigational in the United States, with prior European studies using different allergen products and methodologies.
- Existing evidence from Europe, while extensive, often lacks rigorous controlled, randomized, double-blinded trial designs.
Purpose of the Study:
- To review recent research on the efficacy, safety, and mechanisms of SLIT.
- To focus on studies involving ragweed and grass antigens.
- To evaluate the current state of SLIT research in the United States.
Main Methods:
- Systematic review of studies published within the past year.
- Focus on research pertaining to ragweed and grass allergens.
- Analysis of efficacy, safety, and mechanistic data from clinical trials.
Main Results:
- Recent US-based studies demonstrate the safety of SLIT for allergic rhinitis.
- These studies also confirm the efficacy of SLIT in US populations.
- Emerging data from US trials are beginning to elucidate the mechanisms underlying SLIT.
Conclusions:
- SLIT is a safe and effective treatment option for allergic rhinitis.
- US-specific research is crucial for the broader adoption of SLIT.
- Further investigation into SLIT mechanisms will optimize its clinical application.
Related Concept Videos
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
02:06Allergic Reactions
Overview
01:16Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...